NPPA brings 80 plus medicines under Price Regulation

National Pharmaceutical Pricing Authority (NPPA) NPPA fixes the price of 81 medicines including off-patent anti-diabetic drugs allowing due benefits of patent expiry to the patients.

Daily Current Affairs Quiz 2021

NPPA has fixed the retail price of ‘insulin human injection, 200IU/ml’ and ‘70% isophane insulin human suspension + 30% insulin human injection 200IU/ml’ produced by Wockhardt Ltd at ₹106.65 per ml each (excluding GST) and Prasugrel Hydrochloride 10 mg + Aspirin 75 mg capsule by Torrent Pharmaceuticals Ltd at ₹20.16 per capsule (excluding GST).

The decision was taken because the five-year price exemption given to these medicines on account of indigenous R&D got over recently.

Revision in existing ceiling prices of scheduled formulations based on the Wholesale Price Index (WPI) was also approved by the Authority. The revised prices will be effective from April, 2021.

It also decided to retain the revised ceiling price of Heparin injection up to September this year. Last year, the NPPA had hiked the price of the essential blood thinner on account of rising raw material costs from China. The ceiling price was fixed till March 31 this year.